Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012)
Dexcom (DXCM) reported Non-Current Deffered Revenue of $600000.0 for Q4 2012, up 100.0% year-over-year from $300000.0 in Q1 2012, and up 5.45% on a QoQ basis from $569000.0 in Q3 2012.
Dexcom (DXCM) has 2 years of Non-Current Deffered Revenue data on file, last reported at $600000.0 in Q4 2012.
- Quarterly Non-Current Deffered Revenue rose 100.0% year-over-year to $600000.0 in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $600000.0 (up 100.0% YoY) and the FY2012 annual result came in at $600000.0, up 100.0% from the prior year.
- Non-Current Deffered Revenue rose to $600000.0 in Q4 2012 per DXCM's latest filing, from $569000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $834000.0 in Q1 2012 and bottomed at $300000.0 in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 600,000.00 |
| Sep 30, 2012 | 569,000.00 |
| Jun 30, 2012 | 702,000.00 |
| Mar 31, 2012 | 834,000.00 |
| Dec 31, 2011 | 300,000.00 |